13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 106 holding rows worth $5,280,006,191.
- Accession
- 0001213900-25-014236
- Filer
- CIK 1009258
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 106 entries on the cover page, a total value of $5,280,006,191 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,280,006,191 with VALUE read as dollars as filed, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVALENT INC COM | 670703107 | Stock | 17,991,024 | $1,408,337,359 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 23,996,036 | $298,750,648 | dollars as filed | |
| INTEGRA LIFESCIENCES HLDGS C | 457985AM1 | NOTE 0.500% 8/1 | 174,364,000 | $168,179,309 | dollars as filed | principal |
| CENTENE CORP DEL COM | 15135B101 | Stock | 2,671,921 | $161,864,974 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 11,835,000 | $159,062,400 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,258,332 | $142,519,442 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 2,972,787 | $125,005,693 | dollars as filed | |
| ACCOLADE INC | 00437EAB8 | NOTE 0.500% 4/0 | 132,598,000 | $124,471,069 | dollars as filed | principal |
| WAYSTAR HLDG CORP | 946784105 | COM | 3,295,260 | $120,936,042 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 862,000 | $117,663,000 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC | 02043QAB3 | NOTE 1.000% 9/1 | 110,000,000 | $117,307,300 | dollars as filed | principal |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 10,514,657 | $110,929,631 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 4,314,340 | $110,878,538 | dollars as filed | |
| Indivior PLC | G4766E116 | Common Stock | 8,883,160 | $110,417,679 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749AB7 | NOTE 4.000% 5/0 | 70,000,000 | $106,576,400 | dollars as filed | principal |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 9,711,410 | $92,452,623 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC COM | 01625V104 | Stock | 7,304,302 | $82,173,398 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 21,231,974 | $82,167,739 | dollars as filed | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 15,612,264 | $78,529,688 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,736,000 | $70,315,200 | dollars as filed | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 3,270,535 | $67,536,548 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 5,193,823 | $66,325,120 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 3,133,011 | $65,385,940 | dollars as filed | |
| ACCENDRA HEALTH INC | 690732102 | COM | 4,911,979 | $64,199,566 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 8,144,442 | $61,246,204 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 1,923,100 | $56,077,596 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,078,509 | $55,496,190 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,551,718 | $50,492,904 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 151,644 | $49,816,570 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081GAB8 | NOTE 0.750% 8/0 | 49,500,000 | $46,711,170 | dollars as filed | principal |
| CONMED CORP COM | 207410101 | Stock | 611,964 | $41,882,816 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 3,379,399 | $41,161,080 | dollars as filed | |
| ENHABIT INC | 29332G102 | COM | 5,010,972 | $39,135,691 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,411,000 | $38,802,500 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 2,017,464 | $38,674,785 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 600,515 | $38,072,651 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 145,191 | $34,164,894 | dollars as filed | |
| Lantheus Hldgs Inc Note 2.625 percent 12/1 | 516544AB9 | Convertible | 25,255,000 | $33,708,606 | dollars as filed | principal |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 2,596,033 | $32,891,738 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 1,271,832 | $31,999,293 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 1,795,174 | $31,271,931 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 7,195,956 | $30,510,853 | dollars as filed | |
| INMODE LTD SHS | M5425M103 | Stock | 1,578,708 | $26,364,424 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 7,964,000 | $24,449,480 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 851,593 | $24,423,687 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 593,000 | $23,856,390 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 6,710,429 | $23,486,502 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 500,000 | $23,035,000 | dollars as filed | put |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 1,497,000 | $21,496,920 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 240,218 | $21,489,902 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,631,000 | $20,521,800 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 861,814 | $19,735,541 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 1,018,415 | $19,645,225 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 225,000 | $18,418,500 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 2,315,000 | $15,649,400 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 3,255,514 | $15,366,026 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 156,012 | $14,067,602 | dollars as filed | |
| CHIMERIX INC COM | 16934W106 | Stock | 3,771,342 | $13,124,270 | dollars as filed | |
| CONCENTRA GROUP HOLDINGS PAR | 20603L102 | COMMON STOCK | 650,000 | $12,857,000 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 1,562,942 | $12,800,495 | dollars as filed | |
| ACCOLADE INC | 00437E102 | COM | 3,475,000 | $11,884,500 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 1,019,700 | $10,492,713 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 450,000 | $10,476,000 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 1,534,763 | $10,421,041 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 435,653 | $10,263,985 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 448,145 | $10,244,595 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 373,407 | $10,126,798 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 2,938,754 | $9,374,625 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 3,555,871 | $5,867,187 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 2,155,000 | $5,365,950 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,000,000 | $5,350,000 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 1,300,000 | $4,602,000 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 1,882,654 | $3,897,094 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R308 | COM | 166,162 | $3,228,528 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 583,913 | $2,995,474 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,066,962 | $2,016,558 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 92,787 | $1,322,215 | dollars as filed | |
| BIOMX INC | 09090D301 | COM | 1,787,610 | $1,305,134 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 534,737 | $1,171,074 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 23,827 | $1,107,241 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 3,360,052 | $1,038,256 | dollars as filed | |
| QUANTUM SI INC | 74765K113 | *W EXP 06/10/202 | 333,333 | $416,666 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 917 | $232,652 | dollars as filed | |
| GENERAL MILLS INC COM | 370334104 | Stock | 3,455 | $220,325 | dollars as filed | |
| ENLINK MIDSTREAM LLC | 29336T100 | COM UNIT REP LTD | 10,257 | $145,137 | dollars as filed | |
| HONEST CO INC | 438333106 | COM | 20,171 | $139,785 | dollars as filed | |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 14,058 | $134,394 | dollars as filed | |
| HEARTLAND EXPRESS INC | 422347104 | COM | 11,547 | $129,557 | dollars as filed | |
| UNISYS CORP | 909214306 | COMMON STOCK | 15,627 | $98,919 | dollars as filed | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 733,333 | $93,207 | dollars as filed | |
| VAALCO ENERGY INC | 91851C201 | COMMON STOCK | 20,897 | $91,320 | dollars as filed | |
| HANESBRANDS INC | 410345102 | COM | 10,619 | $86,439 | dollars as filed | |
| GENWORTH FINL INC | 37247D106 | COM SHS | 11,307 | $79,036 | dollars as filed | |
| ECOVYST INC | 27923Q109 | COM | 10,317 | $78,822 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 50,305 | $77,470 | dollars as filed | |
| EQUITY COMMONWEALTH | 294628102 | COM SH BEN INT | 43,258 | $76,567 | dollars as filed | |
| ACCO BRANDS CORP COM | 00081T108 | Stock | 14,557 | $76,424 | dollars as filed | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 20,898 | $75,442 | dollars as filed | |
| NU SKIN ENTERPRISES INC | 67018T105 | CL A | 10,194 | $70,237 | dollars as filed | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 11,990 | $55,754 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 20,166 | $53,642 | dollars as filed | |
| BRC INC A | 05601U105 | COMMON STOCK | 15,029 | $47,642 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 166,666 | $38,333 | dollars as filed | |
| DIVERSIFIED HEALTHCARE TR | 25525P107 | COM SH BEN INT | 15,845 | $36,444 | dollars as filed | |
| The Oncology Institute Inc W Exp 99/99/999 | 68236X118 | SPAC Combination | 1,250,000 | $6,500 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $3,567 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-25-014236 | this filing | 2025-02-14 | acceptance time not in the bulk data set |